Hematopoietic kit deficiency, rather than lack of mast cells, protects mice from obesity and insulin resistance

Summary: Obesity, insulin resistance, and related pathologies are associated with immune-mediated chronic inflammation. Kit mutant mice are protected from diet-induced obesity and associated co-morbidities, and this phenotype has previously been attributed to their lack of mast cells. We performed a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gutierrez, Dario Alejandro (VerfasserIn) , Herzig, Stephan (VerfasserIn) , Rodewald, Hans-Reimer (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: May 5, 2015
In: Cell metabolism
Year: 2015, Jahrgang: 21, Heft: 5, Pages: 678-691
ISSN:1932-7420
DOI:10.1016/j.cmet.2015.04.013
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1016/j.cmet.2015.04.013
Verlag, kostenfrei, Volltext: http://www.sciencedirect.com/science/article/pii/S1550413115001680
Volltext
Verfasserangaben:Dario A. Gutierrez, Sathya Muralidhar, ..., Stephan Herzig, Hans-Reimer Rodewald
Beschreibung
Zusammenfassung:Summary: Obesity, insulin resistance, and related pathologies are associated with immune-mediated chronic inflammation. Kit mutant mice are protected from diet-induced obesity and associated co-morbidities, and this phenotype has previously been attributed to their lack of mast cells. We performed a comprehensive metabolic analysis of Kit-dependent KitW/Wv and Kit-independent Cpa3Cre/+ mast-cell-deficient mouse strains, employing diet-induced or genetic (LepOb/Ob background) models of obesity. Our results show that mast cell deficiency, in the absence of Kit mutations, plays no role in the regulation of weight gain or insulin resistance. Moreover, we provide evidence that the metabolic phenotype observed in Kit mutant mice, while independent of mast cells, is immune regulated. Our data underscore the value of definitive mast cell deficiency models to conclusively test the involvement of this enigmatic cell in immune-mediated pathologies and identify Kit as a key hematopoietic factor in the pathogenesis of metabolic syndrome.
Beschreibung:Gesehen am 03.08.2017
Beschreibung:Online Resource
ISSN:1932-7420
DOI:10.1016/j.cmet.2015.04.013